Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system
- 1 January 2018
- book chapter
- review article
- Published by Elsevier BV
- Vol. 146, 67-84
- https://doi.org/10.1016/b978-0-12-804279-3.00005-8
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosisClinica Chimica Acta; International Journal of Clinical Chemistry, 2013
- The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and ProgressionJournal of Immunology Research, 2012
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple SclerosisArchives of Neurology, 2010
- S100B's double life: Intracellular regulator and extracellular signalBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasisJournal of the American Academy of Dermatology, 2009
- Multiple sclerosisThe Lancet, 2008
- N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometryZeitschrift für Neurologie, 2007
- The role of NCAM in remyelinationNeurological Sciences, 2002